Uroplasty (UPI)
Uroplasty Cash Financing: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
UPI Cash Financing Rankings
| Overall | 56th percentile | 1880 of 4323 |
| Sector | 47th percentile | 261 of 495 in Healthcare |
| Industry | 62nd percentile | 28 of 75 in Medical Appliances & Equipment |
UPI Cash Financing Range, Past 5 Years
| Minimum | -0.3977M | Sep 2008 |
| Maximum | 14.98M | Sep 2010 |
| Average | 1.405M |
About Cash Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activites. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
You may also be interested in these UPI related companies
UPI News
$UPI 200 Day SMA Cross - Price crossed below 200 day SMA (4.081). Confirmed by volume.
about 13 hours ago by TradeIdeasQuant
about 13 hours ago by TradeIdeasQuant
$UPI 200 Day SMA Cross - Price crossed below 200 day SMA (4.0979). Confirmed by volume.
about 4 days ago by TradeIdeasQuant
about 4 days ago by TradeIdeasQuant
Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
May 25, 1:42PM Street Insider
May 25, 1:42PM Street Insider
Morning Movers 05/25: (GNOM) (UPI) (EJ) Higher; (DCTH) (TLB) (GENE) Lower
May 25, 10:39AM Street Insider
May 25, 10:39AM Street Insider
Sales of Uroplasty's Urgent® PC in the U.S. increased 79% to $2.3 million in the fourth quarter
http://stks.co/3ymY $UPI
about 9 days ago by evcgroup
about 9 days ago by evcgroup
Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
May 24, 4:05PM PR Newswire
May 24, 4:05PM PR Newswire
Uroplasty Previews Urgent® PC Presentations at the American Urological Association 2012 Annual Meeting
May 17, 7:00AM PR Newswire
May 17, 7:00AM PR Newswire
Uroplasty To Issue Fourth Quarter And Full Fiscal Year 2012 Financial Results On May 24, 2012
May 16, 12:30PM PR Newswire
May 16, 12:30PM PR Newswire
Uroplasty to Present at the 11th Annual JMP Securities Research Conference
May 07, 4:05PM PR Newswire
May 07, 4:05PM PR Newswire
$UPI forms bullish "Diamond Bottom" chart pattern. http://stks.co/3aq3
about 32 days ago by RecogniaEvents
about 32 days ago by RecogniaEvents
$UPI forms bullish "Bottom Triangle" chart pattern. http://stks.co/3aq1
about 32 days ago by RecogniaEvents
about 32 days ago by RecogniaEvents
Uroplasty announces retirement of non-coverage for Urgent PC for 4.6M beneficiaries in Mid-Atlantic http://stks.co/3XPe $UPI
about 37 days ago by evcgroup
about 37 days ago by evcgroup
$UPI forms bullish "Double Bottom" chart pattern. http://stks.co/36jb
about 66 days ago by RecogniaEvents
about 66 days ago by RecogniaEvents
$UPI http://stks.co/2n2l This stock has been hanging in there nice. $UPI in just below this level.
about 82 days ago by kaneco
about 82 days ago by kaneco
$UPI http://stks.co/2gCH update on the just for fun trade of the day. looks great honestly. $UPI
about 89 days ago by kaneco
about 89 days ago by kaneco
$UPI http://stks.co/2fpx The just for fun play of the day. This could actually fly if she gets back in triangle.
about 89 days ago by kaneco
about 89 days ago by kaneco
Uroplasty Announces Enrollment in CONFIDeNT Clinical Study for Treatment of Fecal Incontinence with Urgent PC http://stks.co/2QaT $UPI
about 107 days ago by evcgroup
about 107 days ago by evcgroup
$UPI filed latest Quarterly Report http://marketbrief.com/upi/10q/quarterly-report/2012/1/26/9203903?s=st
about 127 days ago by MarketBrief
about 127 days ago by MarketBrief
Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
Jan 19, 7:00AM PR Newswire
Jan 19, 7:00AM PR Newswire
Uroplasty weakness creates buying opportunity, says JMP Securities
Dec 13, 9:29AM theflyonthewall.com
Dec 13, 9:29AM theflyonthewall.com
Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Dec 07, 6:00AM PR Newswire
Dec 07, 6:00AM PR Newswire
Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
Nov 09, 7:00AM PR Newswire
Nov 09, 7:00AM PR Newswire
Uroplasty sales to US customers grow 86% driven by 95% increase in Urgent PC and 75% increase in Macroplastique $UPI http://stks.co/q3H
about 219 days ago by evcgroup
about 219 days ago by evcgroup
StockTwits50 Intersected with "No Chasing Allowed" = $NFLX $PSMT $TSU $UPI
about 341 days ago by stockspot
about 341 days ago by stockspot
$UPI http://chart.ly/gywqe5w Updated. 50d bounce this week. 20d was R today. STO x^ potential has my interest here now.
about 350 days ago by 1nvestor
about 350 days ago by 1nvestor
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| UPI | 4.07 | -0.57 | -12.28% | 96.56M |
| UPG | 1.962 | +0.00 | +0.10% | 9.839M |
| UNTY | 6.09 | -0.04 | -0.65% | 45.73M |
| UNTD | 4.00 | +0.05 | +1.27% | 356.13M |
| UNT | 38.68 | -1.11 | -2.79% | 1.935B |
| UHS | 37.30 | -1.45 | -3.74% | 3.748B |
| UHAL | 81.60 | -2.52 | -3.00% | 1.650B |
| UGP | 20.17 | -0.25 | -1.22% | 4.037B |
| UGL | 82.62 | +6.00 | +7.83% | |
| UGI | 28.38 | -0.30 | -1.05% | 3.216B |
